Business & FinanceTop StoryTop StoryLatest News
Emcure Pharma Q2FY27 Results: Net Profit Rises 29.31% to ₹325 Crore
Sentiment: NeutralHigh Priority
What Happened?
Emcure Pharmaceuticals reported a 29.31% increase in net profit to ₹325.06 crore for Q2FY27, driven by strong international business growth. Revenue rose to ₹2,820.47 crore.
Key points
- Net profit for Q2FY27 reached ₹325.06 crore, up from ₹251.37 crore a year ago.
- Revenue from operations increased to ₹2,820.47 crore compared to ₹2,269.82 crore last year.
- Total expenses rose to ₹2,377.87 crore from ₹1,931.52 crore a year earlier.
- International business grew by 34% to ₹1,665.2 crore, while domestic business rose by 11.1% to ₹1,155.3 crore.
- Europe's international business grew by 36%, Canada by 24%, and other markets by 41.1%.
- For H1FY27, profit was ₹617.56 crore, a 32.47% increase from ₹466.16 crore in the previous year.
Key insights
- Sustained growth in international markets may lead to increased market share for Emcure.
- The rise in domestic revenue suggests a strengthening position in the Indian pharmaceutical market.
- Investors may view the strong quarterly performance as a positive indicator for future growth.
Why it matters
The results indicate strong growth in Emcure's international business, which could influence investor confidence.
Tags
Entities
Emcure Pharmaceuticals· CompanyIndia· Country
Source
Business Standard
